Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

Medtronic enrolls first patient for head-to-head EVAR study

The randomized trial, expected to enroll at least 550 patients, will follow patients for a total of five years.

Samir Kapadia, MD, Cleveland Clinic TAVR transcatheter aortic valve replacement

Q&A: Discussing TAVR trends with cardiologist Samir Kapadia of Cleveland Clinic

What's next for TAVR? What trends should clinicians be focused on as time goes on? Kapadia shared his perspective in a new interview. 

AVS Pulse PIVL

Interventional cardiology specialists raise $20M to continue IVL research

AVS, a Michigan-based medical device company, has said the funding will help accelerate research on its new Pulse P-IVL system. One clinical trial is already underway. 

The Shimadzu Trinias SCORE Opera Angiography system at RSNA 2022. It offers dose lowering technologies and workflow efficiencies. #RSNA #RSNA22

VIDEO: Shimadzu lowers dose and speeds workflow with new Trinias SCORE Opera angiography system

Sponsored by Shimadzu

Shimadzu Medical Systems USA released the latest version of its Trinias angiography system at the Radiological Society of North America (RSNA) 2022 meeting to address radiation concerns and to help improve workflow.
 

Radiation and workflow concerns addressed in new Shimadzu angiography system

To address radiation concerns by interventionalists and to help speed workflows in cath labs, Shimadzu released new AI features and single button push features for table and C-arm movement. 

An example of virtual pulmonary valve implant planning software showing a virtual transcatheter pulmonary valve with measurements implnated in the virtual anatomy of a congenital heart patient. This was part of a training class at the Society of Cardiovascular Computed Tomography (SCCT) 2022 meeting.

FDA makes clearance easier for cardiac device implant simulation software

The FDA is reclassifying interventional cardiovascular implant simulation software into the class II (special controls) regulatory category, which will make it easier for the technology to pass regulatory approval. 

Minima Stent Cedars Sinai adjustable children cardiology

Cardiologists explore the real-world potential of new adjustable stents for children

The new-look adjustable stents, not yet fully approved by the FDA, can be expanded as a child ages. The hope is that these stents will never need to be replaced.

Cardiologist the subject of several malpractice claims for allegedly performing unnecessary heart operations

One patient received a total of 41 stents from 2004 to 2013. He said the experience was so hard that he feared he would be driven to suicide.